VRK1 Promotes Cisplatin Resistance by Up-Regulating C-Myc via C-Jun Activation and Serves as a Therapeutic Target in Esophageal Squamous Cell Carcinoma
Oncotarget - United States
doi 10.18632/oncotarget.20020
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 7, 2017
Authors
Publisher
Impact Journals, LLC